Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

GLSI holding history

Greenwich LifeSciences, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GLSI overviewAll 13F holders of GLSIFull Q2 2026 holdings

Shares (Q2 2026)
23,409
Value
$549.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GLSI by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202623,409$549.2K<0.1%+2,293+10.9%AddedHolders
Q1 202621,116$507.2K<0.1%+15,036+247.3%AddedHolders
Q4 20256,080$127.7K<0.1%+1,974+48.1%AddedHolders
Q3 20254,106$40.9K<0.1%+2,261+122.5%AddedHolders
Q2 20251,845$16.7K<0.1%−1,351−42.3%ReducedHolders
Q1 20253,196$30.5K<0.1%−3,361−51.3%ReducedHolders
Q4 20246,557$73.6K<0.1%+3,750+133.6%AddedHolders
Q3 20242,807$40.3K<0.1%+1,000+55.3%AddedHolders
Q2 20241,807$31.2K<0.1%+1,405+349.5%AddedHolders
Q1 2024402$8.02K<0.1%−1,438−78.2%ReducedHolders
Q4 20231,840$19.4K<0.1%+1,839+183,900.0%AddedHolders
Q3 20231$9<0.1%−227−99.6%ReducedHolders
Q2 2023228$2.20K<0.1%+227+22,700.0%AddedHolders
Q1 20231$14<0.1%−723−99.9%ReducedHolders
Q4 2022724$11.0K<0.1%−1,085−60.0%ReducedHolders
Q3 20221,809$17.0K<0.1%+939+107.9%AddedHolders
Q2 2022870$7.00K<0.1%+45+5.5%AddedHolders
Q1 2022825$16.0K<0.1%−1,939−70.2%ReducedHolders
Q4 20212,764$67.0K<0.1%−1,546−35.9%ReducedHolders
Q3 20214,310$168.0K<0.1%+3,550+467.1%AddedHolders
Q2 2021760$34.0K<0.1%+451+146.0%AddedHolders
Q1 2021309$11.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.